Shoulder Innovations names new CFO

GRAND RAPIDS–Shoulder Innovations Inc., a Grand Rapids-based manufacturer of shoulder implants, announced the hiring of Jeff Points as CFO. Points has 25 years of finance experience in high-growth organizations, most recently as CFO at Cardiovascular Systems where he had overall financial responsibility for the organization.

Following SI’s recent securing of significant financial resources, Points will bring the company to the next level of financial rigor and discipline in execution. He will be responsible for leading all financial and IT aspects for the business.

“I am delighted to be joining (Shoulder Innovations CEO) Rob (Ball) and the terrific team at SI to help drive the continued momentum of the business,” Points said. “SI operates in a very large, fast-growing market, and I am excited to support the robust growth of the business and help the company reach its full potential.”

SI also announced the hiring of Jon Osborne as vice president of commercial development. Osborne was most recently vice president of commercial marketing at Smith & Nephew, where he focused on sports medicine.

Said Ball: “I could not be more excited and flattered to have two executives of this caliber and experience join our small team. The Shoulder Innovations team has accomplished much with a lean and efficient team. Augmenting our leadership will allow us to continue to improve our ability to scale our successful business and execute our plans with precision.”

Shoulder Innovations is a privately held medical device development company that designs and commercializes innovative products that demonstrate the potential for improved patient care and reduced overall cost to the healthcare system.

Leveraging its breakthrough, patented InSetglenoid design, Shoulder Innovations is commercializing a shoulder replacement implant system focused on improving outcomes related to the greatest cause of shoulder replacement failure: glenoid loosening.

The InSet technology has been shown in testing to significantly reduce glenoid implant micro-motion and simplifies the surgical technique, potentially reducing complications or increasing implant longevity.

More at

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.